IP Library Granted Patent US 7,138,513
Granted Patent B2
US 7,138,513 · App. 10/494,541 · Granted Nov 21, 2006

Genes encoding for genetic stability, gene expression and folding proteins

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,138,513
App. No.
10/494,541
Granted
Nov 21, 2006
Kind
B2
Abstract

The invention relates to novel nucleic acid molecules, to the use thereof for constructing genetically improved microorganisms and to methods for preparing fine chemicals, in particular amino acids, with the aid of said genetically improved microorganisms.

Claims (23)

1. An isolated nucleic acid molecule selected from the group consisting of:

a) an isolated nucleic acid molecule encoding the amino acid sequence set forth in SEQ ID NO:2, wherein either (i) the amino acid residue at position 337 of SEQ ID NO:2 is any amino acid except proline; (ii) the amino acid residue at position 405 of SEQ ID NO:2 is any amino acid except threonine; or (iii) the amino acid residue at position 504 of SEQ ID NO:2 is any amino acid except proline; or a complement thereof;

b) an isolated nucleic acid molecule comprising the nucleotide sequence set forth in SEQ ID NO:1, wherein the nucleic acid molecule comprises one or more nucleic acid modifications as compared to the nucleotide sequence set forth in SEQ ID NO:1 such that either (i) nucleotide residues 1109–1111 of SEQ ID NO:1 encode any amino acid except proline; (ii) nucleotide residues 1313–1315 of SEQ ID NO:1 encode any amino acid except threonine or (iii) nucleotide residues 1610–1612 of SEQ ID NO:1 encode any amino acid except proline; or a complement thereof; and

c) an isolated nucleic acid molecule comprising the nucleotide sequence set forth in SEQ ID NO:1, wherein the nucleic acid molecule comprises one or more nucleic acid modifications either (i) at nucleotide residues 1109–1111 of SEQ ID NO:1 such that nucleotide residues 1109–1111 of SEQ ID NO:1 encode any amino acid except proline; (ii) at nucleotide residues 1313–1315 of SEQ ID NO:1 such that nucleotide residues 1313–1315 of SEQ ID NO:1 encode any amino acid except threonine or (iii) at nucleotide residues 1610–1612 of SEQ ID NO:1 such that nucleotide residues 1610–1612 of SEQ ID NO:1 encode any amino acid except proline; or a complement thereof.

2. The isolated nucleic acid molecule of claim 1 (a) wherein the amino acid residue at position 337 of SEQ ID NO:2 is serine.

3. A vector, comprising the nucleic acid molecule of claim 1 .

4. The vector of claim 3 , which is an expression vector.

5. An isolated host cell, which is transfected with the vector of claim 4 .

6. The host cell of claim 5 , wherein expression of said nucleic acid molecule modulates the production of a fine chemical from said cell.

7. A method for preparing a fine chemical, comprising culturing the cell of claim 5 such that the fine chemical is produced.

8. The method of claim 7 , wherein the fine chemical is an amino acid.

9. The method of claim 8 , wherein said amino acid is lysine.

10. The host cell of claim 5 , wherein said cell is a microorganism.

11. The host cell of claim 10 , wherein said cell belongs to the genus Corynebacterium or Brevibacterium.

12. The host cell of claim 6 , wherein said fine chemical is selected from the group consisting of organic acids, proteinogenic and nonproteinogenic amino acids, purine and pyrimidine bases, nucleosides, nucleotides, lipids, saturated and unsaturated fatty acids, diols, carbohydrates, aromatic compounds, vitamins, cofactors and enzymes.

13. The method of claim 7 , wherein said cell belongs to the genus Corynebacterium or Brevibacterium.

14. The method of claim 7 , wherein expression of the nucleic acid molecule from said vector results in modulation of production of said fine chemical.

15. A method for producing a fine chemical, comprising culturing a cell whose genomic DNA has been altered by the inclusion of a nucleic acid molecule of claim 1 .

16. The isolated nucleic acid molecule of claim 1 (a) wherein the amino acid residue at position 405 of SEQ ID NO:2 is isoleucine.

17. The isolated nucleic acid molecule of claim 1 (a) wherein the amino acid residue at position 504 of SEQ ID NO:2 is serine.

18. The nucleic acid molecule of claim 1 (b) or (c), wherein nucleotide residues 1109–1111 of SEQ ID NO:1 encode serine.

19. The isolated nucleic acid molecule of claim 1 (b) or (c), wherein nucleotide residues 1313–1315 of SEQ ID NO:1 encode isoleucine.

20. The isolated nucleic acid molecule of claim 1 (b) or (c), wherein nucleotide residues 1610–1612 of SEQ ID NO:1 encode serine.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 11, 2016
From: PAIK KWANG INDUSTRIAL CO., LTD.
To: DAESANG CORP.
Reel/Frame 038241/0026 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT COUNTRY LISTED FOR ASSIGNEE PREVIOUSLY RECORDED ON REEL 021383 FRAME 0328. ASSIGNOR(S) HEREBY CONFIRMS THE CORRECT ASSIGNEE COUNTRY FROM DEM REP OF KOREA TO REPUBLIC OF KOREA. Recorded Sep 19, 2008
From: BASF SE
To: PAIK KWANG INDUSTRIAL CO., LTD.
Reel/Frame 021560/0180 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 13, 2008
From: BASF SE
To: PAIK KWANG INDUSTRIAL CO., LTD.
Reel/Frame 021383/0328 →
CHANGE OF NAME Recorded Jun 5, 2008
From: BASF AKTIENGESELLSCHAFT
To: BASF SE
Reel/Frame 021062/0658 →
CHANGE OF NAME Recorded May 23, 2008
From: BASF AKTIENGESLLSCHAFT
To: BASF SE
Reel/Frame 021003/0981 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 19, 2004
From: ZELDER, OSKAR; POMPEJUS, MARKUS; SCHRODER, HARTWIG; KROGER, BURKHARD; KLOPPROGGE, CORINNA; HABERHAUER, GREGOR
To: BASF AKTIENGESELLSCHAFT
Reel/Frame 015581/0058 →